用肘 发表于 2025-3-25 05:04:37

http://reply.papertrans.cn/67/6659/665854/665854_21.png

冷淡周边 发表于 2025-3-25 10:37:21

http://reply.papertrans.cn/67/6659/665854/665854_22.png

LATER 发表于 2025-3-25 15:44:05

Interleukin-15, adaptive immune system. It binds to a heterotrimeric receptor consisting of the common γ-chain receptor, IL-15/IL-2 receptor β-chain and unique IL-15 receptor α-chain. IL-15 is expressed at the mRNA level in a variety of cell lineages and is expressed as protein as part of the rapid early inflammat

Leaven 发表于 2025-3-25 17:34:27

IL-17 and Th17 cells, key players in arthritis,rged as the best-studied situation to justify the selection of IL-17 as a therapeutic target. By interacting with other proinflammatory cytokines, IL-17 was found to induce bone and cartilage destruction. In 2006, the precise cell source of IL-17 was identified in the mouse. These cells were named T

要塞 发表于 2025-3-25 23:50:04

http://reply.papertrans.cn/67/6659/665854/665854_25.png

巨大没有 发表于 2025-3-26 01:03:18

http://reply.papertrans.cn/67/6659/665854/665854_26.png

创新 发表于 2025-3-26 06:30:27

http://reply.papertrans.cn/67/6659/665854/665854_27.png

预防注射 发表于 2025-3-26 11:27:55

http://reply.papertrans.cn/67/6659/665854/665854_28.png

farewell 发表于 2025-3-26 13:57:33

http://reply.papertrans.cn/67/6659/665854/665854_29.png

招募 发表于 2025-3-26 17:17:00

Perspectives in targeted therapy,lity of animal models for development of targeted therapies, clinical trial design, pharmacodynamics, immunobiology and key pathogenic elements of disease. Studies of chimeric anti-CD4 monoclonal antibodies in RA demonstrated the need for pre-clinical studies to more closely approximate the human th
页: 1 2 [3] 4 5
查看完整版本: Titlebook: New Therapeutic Targets in Rheumatoid Arthritis; Paul-Peter Tak Book 2009 Birkhäuser Basel 2009 Arthritis.Chemokine.Drug Target.Interleuki